JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Research Grade Istiratumab is a bispecific human monoclonal antibody which targets human Insulin-like growth factor 1 receptor and Receptor tyrosine-protein kinase erbB-3.